ANIP Stock Analysis: Buy, Sell, or Hold?
ANIP - ANI Pharmaceuticals, Inc.
$86.03
2.98 (3.59%)
▲
5d:
+3.3%
30d:
+15.24%
90d:
+13.26%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 14, 2026
Get Alerted When ANIP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ANIP shows positive signals but monitor for confirmation. Market pricing in 1.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ANIP shows positive signals but monitor for confirmation. Market pricing in 1.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$136.83
Based on 9.1% avg growth
INTRINSIC VALUE TODAY
$84.96
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANIP is currently trading at $86.03, which is considered extended relative to its 30-day fair value range of $78.59 to $83.74. The stock's valuation (Forward PE: 8.0) is in line with its historical norms (8.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This pessimistic expectation contrasts with the company's recent 86.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ANIP is in a uptrend. The price is approaching resistance at $86.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: ANIP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.71 (+31.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANIP is in a uptrend. The price is approaching resistance at $86.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: ANIP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.71 (+31.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$78.59 -
$83.74
Company Quality Score
64/100
(BUY)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 36th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 31.0% below Wall St target ($112.71)
Trading Range Analysis
30-Day Trading Range
$78.59 -
$83.74
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$5.40
(6.3%)
Support & Resistance Levels
Support Level
$78.38
Resistance Level
$86.13
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.04
Wall Street Target
$112.71
(+31.0%)
Revenue Growth (YoY)
20.5%
Earnings Growth (YoY)
86.1%
Profit Margin
10.0%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
8.0 vs 8.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$85.17
(-1%)
2-Year Target
$84.32
(-2%)
3-Year Target
$83.47
(-3%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
$86.13
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 14.2%)
$346.72
(+303%)
Base:
(SPY PE: 8.0, Growth: 14.2%)
$128.05
(+49%)
Bear:
(PE: 6.8, Growth: 14.2%)
$108.85
(+27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 21.24 | Current EPS (TTM): $3.91
Bull Case
$182.71
(+112%)
Analyst growth 100.0%, PE expands to 23.4
Base Case
$166.10
(+93%)
Market implied 100.0%, PE stable at 21.2
Bear Case
$56.47
(-34%)
Severe decline -20.0%, PE contracts to 18.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.0 to 8.3
Stabilization Target:
$88.77
(+3.2%)
PE Expansion Potential:
+3.2%
Share & Embed Analysis
Last updated: July 03, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM
Data refreshes hourly during market hours. Next update: 9:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANIP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Meredith Cook
SELL
500 shares
2026-04-13
Meredith Cook
SELL
500 shares
2026-03-13
Christopher Mutz
SELL
3162 shares
2026-03-13
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
Advanced ANIP Option Strategies
Professional options setups generated by AI based on today's ANIP price and gamma walls.